Visual prognosis in extremely old patients with temporal (giant cell) arteritis [3]

Journal of the American Geriatrics Society

Volumn 51, Issue 5, 2003, Pages 722-723

  Liozon, Eric ^b   Loustaud Ratti, Véronique ^b   Ly, Kim ^b   Soria, P ^b   Vidal, Elisabeth ^b   Boutros Toni, Fernand ^b   Robert, Pierre Yves ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PREDNISONE;

AGING; BLINDNESS; BLOOD VESSEL BIOPSY; CENTRAL RETINA ARTERY OCCLUSION; CLAUDICATION; CLINICAL PROTOCOL; CLINICAL STUDY; DIPLOPIA; DISEASE COURSE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FATALITY; FOLLOW UP; GERIATRIC PATIENT; GIANT CELL ARTERITIS; HEADACHE; HEALTH HAZARD; HUMAN; INCIDENCE; INTERNAL MEDICINE; ISCHEMIC OPTIC NEUROPATHY; LETTER; LIFE EVENT; OPHTHALMOLOGY; OPHTHALMOSCOPY; PHYSICIAN; PROGNOSIS; QUESTIONNAIRE; SIDE EFFECT; SYMPTOM; TEMPORAL ARTERITIS; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; PREDNISONE; PROGNOSIS; QUESTIONNAIRES; TEMPORAL ARTERITIS; VISION DISORDERS;

EID: 0037732676     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0579.2003.00223.x     Document Type: Letter

References (13)

1. de Keyser J, De Klippel N, Ebinger G. Thrombocytosis and ischaemic complications in giant cell arteritis. BMJ 1991;303:825.
2. Aiello PD, Trautmann JC, McPhee TJ et al. Visual prognosis in giant cell arteritis. Ophthalmology 1993;4:550-555.
3. Liu GT, Glaser JS, Schatz NJ et al. Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. Ophthalmology 1994;101:1779-1785.
4. Cid MC, Font C, Oristrell J et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998;41:26-32.
5. Font C, Cid MC, Coll-Vinent B et al. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol 1997;36:251-254.
6. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998;125:509-520.
7. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Arthritis Rheum 1998;41:1497-1504.
8. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:383-392.
9. Liozon E, Herrmann FR, Ly K et al. Risk factors for visual loss in temporal arteritis. A prospective study of 174 patients. Am J Med 2001;111:211-217.
10. Simmons RJ, Cogan DG. Occult temporal arteritis. Arch Ophthalmol 1962;68:38-48.
11. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of occult giant cell arteritis. Am J Ophthalmol 1998;125:521-526.
12. Hollenhorst RW, Brown JR, Wagener HP. Neurologic aspects of temporal arteritis. Neurology 1960;10:490-498.
13. Hachulla E, Boivin U, Pasturel-Michon AL et al. Prognostic and long term evolution in a cohort of 133 patients with giant cell temporal arteritis. Clin Exp Rheum 2001;19:171-176.